Inventage Lab (XKRX:389470) Debt-to-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Debt-to-Asset?

Inventage Lab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0.0 Mil. Inventage Lab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0.0 Mil. Inventage Lab's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₩42,806.3 Mil. Inventage Lab's debt to asset for the quarter that ended in Mar. 2024 was 0.00.

Inventage Lab Debt-to-Asset Historical Data

The historical data trend for Inventage Lab's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Debt-to-Asset Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.35

0.22

0.13

0.08

0.24

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial					0.08	0.14	0.22	0.24	-

Competitive Comparison of Inventage Lab's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inventage Lab's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Inventage Lab's Debt-to-Asset falls into.

Inventage Lab Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Inventage Lab's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4478.131	+	6236.167)	/	45182.343
	=	0.24

Inventage Lab's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	42806.302
	=	0.00

Inventage Lab (XKRX:389470) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Inventage Lab Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines